Artivion press release (AORT): Q3 Non-GAAP EPS of -$0.05.Revenue of $76.8M (+6.4% Y/Y).Full year revenues are now expected to be between $313.0 million and $316.0 million
The Office of Senator Tina Smith reported a purchase of Artivion (NYSE: AORT ) stock on October 17, 2022. According to the October filing, the transaction was made on October 17, 2022. What Happened: A Periodic Transaction Report from the U.S. Senate''s Office on October 17, 2022 showed that Smith bought $50,001 - $100,000 of Artivion stock. Artivion shares are trading down 0.7% at $10.92 at the time of writing. Why Congressional Transactions Matter Congressional transactions shouldn''t be used primarily to make an investing decision, however, they can be an important factor for an … Full story available on Benzinga.com
Artivion''s decision to pull PROACT Xa trial resulted in heavy downside for its share price. Investors sold positions rapidly such that AORT stock trades at multi-year lows. Read more here.